Nasus Pharma to present NS002 intranasal epinephrine study results
Tweet Send to a Friend
Nasus Pharma Ltd. (NYSE: NSRX) announced it will host a conference call on March 16, 2026, at 8:00 a.m. ET ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


